Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
Pingping Hou, Xingdi Ma, Zecheng Yang, et al.
Genes & Development (2021) Vol. 35, Iss. 19-20, pp. 1327-1332
Open Access | Times Cited: 24

Showing 24 citing articles:

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T. Hoffman, Laleh Abbassi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2135-2161
Closed Access | Times Cited: 44
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer
Daoyan Wei, Liang Wang, Xiangsheng Zuo, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 655-662
Open Access | Times Cited: 41
Macropinocytosis: mechanisms and regulation
Gilbert Salloum, Anne R. Bresnick, Jonathan Backer
Biochemical Journal (2023) Vol. 480, Iss. 5, pp. 335-362
Closed Access | Times Cited: 40
KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Yunkai Yang, Huan Zhang, Shanshan Huang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 709-709
Open Access | Times Cited: 31
Macropinocytosis at the crossroad between nutrient scavenging and metabolism in cancer
Elena Rainero
Current Opinion in Cell Biology (2024) Vol. 88, pp. 102359-102359
Open Access | Times Cited: 7
The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer
Zhen-Yuan Shi, Changyun Li, Ru-Yi Chen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107400-107400
Closed Access | Times Cited: 6
The Role and Therapeutic Potential of Macropinocytosis in Cancer
Zejing Qiu, Wen‐Cheng Liu, Qianru Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Insights Into the Properties, Biological Functions, and Regulation of USP21
Tao An, Yanting Lu, Yan Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD)
Yuhan Yang, Lei Cao, Zengya Guo, et al.
Experimental Cell Research (2022) Vol. 421, Iss. 2, pp. 113402-113402
Closed Access | Times Cited: 16
RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway
Shiyu Chen, Kun Cai, Dijie Zheng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 15
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
Enrico Gurreri, Giannicola Genovese, Luigi Perelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9313-9313
Open Access | Times Cited: 9
Conquering oncogenic KRAS and its bypass mechanisms
Pingping Hou, Yingshuang Wang
Theranostics (2022) Vol. 12, Iss. 13, pp. 5691-5709
Open Access | Times Cited: 12
The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy
Yongmei Wang, Saisai Li, Wenqin Wang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
MARK3 kinase: Regulation and physiologic roles
Jingyu Yang, Heng Niu, ShiGui Pang, et al.
Cellular Signalling (2022) Vol. 103, pp. 110578-110578
Closed Access | Times Cited: 8
Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
Ruining Gong, Yonglu Hu, Qian Yu, et al.
Journal of Pancreatology (2023) Vol. 6, Iss. 4, pp. 185-195
Open Access | Times Cited: 4
Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1
Jun-Jun Lin, Ye-Cai Lu
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 1006-1018
Open Access | Times Cited: 1
Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism
Yu Ma, Sunkai Ling, Yuan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6697-6697
Open Access | Times Cited: 4
Ubiquitin signaling in pancreatic ductal adenocarcinoma
Shengnan Lv, Jian Zhang, Xinyu Peng, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation
Howard C. Crawford
Genes & Development (2021) Vol. 35, Iss. 19-20, pp. 1325-1326
Open Access | Times Cited: 4
The recombinant defensin/HSA fusion protein that inhibits NF-κb associated with intensive macropinocytosis shows potent efficacy against pancreatic cancer
Yibo Du, Xiaofei Wang, Xiujun Liu, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115057-115057
Closed Access | Times Cited: 3
Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors
Priyanka Sahu, Ankita Mitra, Anirban Ganguly
International review of cell and molecular biology (2024), pp. 167-222
Closed Access
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers
Mitsunobu Takeda, Madelaine Skolastika Theardy, Alexey V. Sorokin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
KRAS inhibition activates an actionable CD24 ‘don’t eat me’ signal in pancreas cancer
Yongkun Wei, Minghui Liu, Er-Yen Yen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Development of prognostic index based on necroptosis-related genes in patient with hepatocellular carcinoma
Xiangfan Hua, Junjun Sun, Weifeng Liu, et al.
Research Square (Research Square) (2022)
Closed Access
Page 1

Scroll to top